FilingSEC EDGAR6-K
Addex Therapeutics announces management changes
· SEC accepted
StageManagement change
Filing content
Addex Therapeutics has appointed Jean-Philippe Rocher as Head of Pharmaceutical Development and announced the departure of Mikhail Kalinichev from his role as Head of Translational Science.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…